Overview

The Effect of Milnacipran in Patients With Fibromyalgia

Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
Use of the drug Milnacipran will reduce ventricular lactate levels and processing time for completing complex tasks relative to placebo.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Beth Israel Medical Center
Treatments:
Levomilnacipran
Milnacipran